US Patent Issued to Aligos Therapeutics on Sept. 30 for "Methods and compositions for targeting PD-L1" (Belgian Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,427, issued on Sept. 30, was assigned to Aligos Therapeutics Inc. (South San Francisco, Calif.).

"Methods and compositions for targeting PD-L1" was invented by Tongfei Wu (Boortmeerbeek, Belgium), Pierre Jean-Marie Bernard Raboisson (Wavre, Belgium) and Francois Gonzalvez (Antwerp, Belgium).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure related to compounds that can be useful as inhibitors of PD-1, PD-L1 or the PD-1/PD-L1 interaction. Also disclosed herein are pharmaceutical compositions of that can include a compound of Formula (I), or a pharmaceutically acceptable salt thereof, and uses of or methods of using a compound of F...